Compare CVS Health Corp (CVS) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while Direxion Daily Semiconductor Bear 3X Shares trades at $42.47. The key difference: CVS Health Corp pays a 2.78% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals.
| CVS | SOXS | |
|---|---|---|
Market Cap | $122.36B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $110.60 | $1.49K |
52-Week Low | $65.51 | $32.50 |
Enterprise Value | $184.71B | — |
Dividend Yield | 2.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $42.08, down 6.18% over 24 hours amid a bearish technical signal. Recent news highlights its inverse leverage benefiting from semiconductor sector weakness, with a 1:10 stock split scheduled for July 2026. Technical indicators show oversold conditions with an RSI of 8.06, while support sits at $40.
The outlook remains risky due to its leveraged inverse structure, which amplifies losses if semiconductor stocks rebound. Opportunities exist for short-term traders betting on continued chip sector declines, but long-term holders face decay and volatility risks. Key risks include AI-driven semiconductor rallies and macroeconomic shifts affecting tech demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
